The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer.
Sherilyn Alvaran Tuazon
No relevant relationships to disclose
Gentry Teng King
No relevant relationships to disclose
Joanna Sta. Cruz
No relevant relationships to disclose
Young K. Chae
No relevant relationships to disclose
Jean B. Ong Kian Koc
No relevant relationships to disclose
Sarah Hegarty
No relevant relationships to disclose
John Charles Leighton
No relevant relationships to disclose